logo

Enter Symbol

PERRIGO CO(NSDQ:PRGO)
Perrigo Company, is the nations largest manufacturer of store brand over-the-counter (non-prescription) pharmaceutical products and also manufactures store brand nutritional products. Store brand products are sold by national and regional supermarket, drugstore and mass merchandise chains under their own labels and compete with nationally advertised brands. The Company''s products include analgesics, cough and cold remedies, antacids, laxatives, feminine hygiene and smoking cessation products, and vitamins, nutritional supplements and nutritional drinks.
# Employees: 7250
Address: 515 Eastern Avenue,Allegan,MI,USA
Phone: 269 673-8451
Fax: 269 673-7534
Website: www.perrigo.com
Email: investor@perrigo.com
Sector: Retail/Wholesale
Industry: MED-WHSL DRG/SN
Executive Officers
Thomas M. Farrington (Sr. V.P.; Chief Inf. Off.)
Jeffrey R. Needham (Sr. V.P. Commercial Bus. Devept.)
Joseph C. Papa (Presi.; C.E.O.)
Michael R. Stewart (Sr. V.P.; Global Human Resources)
Louis W. Yu Ph.D. (Sr. V.P.; Global Quality & Compliance,)
Dividend
Ex-Dividend Date: 8/26/2009
Annual Dividend: $0.22
Current Dividend Yield: $0.56
Dividend Paid (3 months): $0.05
Indicated Dividend: $0.10
Earnings
Last Earnings Date: 9/30/2009
Next Earnings Date(Expected): 2/9/2010
Mean EPS (Next Qtr): $0.65
Mean EPS (Year): $2.42
Mean Estimate(Long Term): $15.68
P/E Ratio(Based on EPS estimate): 16.270
Number of Estimates: 10
Shares Performance
Period PRGO Compare to S&P
YTD 21.67 % 0.69 %
4 Weeks 6.91 % 5.75 %
12 Weeks 32.09 % 24.53 %
Shares Information
Analyst Coverage: Y
Avg Volume: 811331
Shares Outstanding: 92M
Market Cap: $3.62B
52 Week High: $40.19
52 Week Low: $18.89
P/E Ratio: 18.450
PEG Ratio: 1.040
Split: On 8/26/1993 PRGO split by factor of 2.000
Earnings Performance
EPS Growth in Last Quarter: 32.00 %
EPS Growth in Last Year: 60.98 %
Sales Growth in Last Quarter: 3.89 %
Sales Growth in Last Quarter: 9.95 %
Financials
Qtr Book Value: $3.73
Cash Flow/Share: $14.81
Change in Payout Ratio: -0.070
Price/Sales: 1.720
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia